Cholinesterase and Neurodegenerative Diseases
Cholinesterase and Neurodegenerative Diseases is a research topic within Pharmacology. Science Explorer counts 31k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pharmacology and toxicology of cholinesterase inhibitors, particularly acetylcholinesterase and butyrylcholinesterase, in the context of neurodegenerative diseases such as Alzheimer's. It explores the development of multi-target-directed ligands, novel drug therapies, and the implications for cognitive deficits. The research also delves into the structure, function, and regulation of cholinesterases, as well as their potential roles in neuroprotection and neurorestoration.
- Cholinesterase Inhibitors
- Acetylcholinesterase
- Butyrylcholinesterase
- Alzheimer's Disease
- Neurodegenerative Diseases
- Multi-Target-Directed Ligands
- Pharmacology
- Toxicology
- Drug Development
- Cognitive Deficits
- Research works
- 31k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +12% the tick is no change
- Largest producer
China
25% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cholinesterase and Neurodegenerative Diseases research?
By volume, China and India publish the most (829 and 800 works in 2022-now).
By volume, 2022-now
- 1
China 829 works
- 2
India 800 works
- 3
United States 638 works
- 4
Türkiye 279 works
- 5
Italy 153 works
- 6
Brazil 142 works
- 7
South Korea 130 works
- 8
Iran 122 works
- 9
Russia 121 works
- 10
Pakistan 115 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cholinesterase and Neurodegenerative Diseases research?
By volume in 2022-now, Russian Academy of Sciences publishes the most Cholinesterase and Neurodegenerative Diseases research, followed by Chinese Academy of Sciences and Harvard University.
By volume, 2022-now
- 1
Russian Academy of Sciences
Russia 55 works
- 2
Chinese Academy of Sciences
China 34 works
- 3
Harvard University
United States 26 works
- 4
University of Florence
Italy 21 works
- 5
Banaras Hindu University
India 20 works
- 6
Centre National de la Recherche Scientifique
France 19 works
- 7
King Saud University
Saudi Arabia 18 works
- 8
Cairo University
Egypt 17 works
- 9
National Research Council
Italy 16 works
- 10
Islamic Azad University, Tehran
Iran 16 works
Who are the leading researchers in Cholinesterase and Neurodegenerative Diseases?
The most-cited researchers publishing on Cholinesterase and Neurodegenerative Diseases include Jun Wang, John Q. Trojanowski and Luigi Ferrucci.
- 1
Jun Wang
China 340k citations
- 2
John Q. Trojanowski
United States 286k citations
- 3
Luigi Ferrucci
United States 281k citations
- 4
Matthew M. Meyerson
United States 280k citations
- 5
Wei Huang
China 267k citations
- 6
Ben Zhong Tang
China 261k citations
- 7
Amirhossein Sahebkar
Iran 258k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cholinesterase and Neurodegenerative Diseases research done?
The largest centres of Cholinesterase and Neurodegenerative Diseases research in 2022-now are Beijing (China), Seoul (South Korea), New Delhi (India) and Moscow (Russia).
Where is the best place to study Cholinesterase and Neurodegenerative Diseases?
Among universities, judged by research, Harvard University, Central University of Punjab and Atatürk University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Cholinesterase and Neurodegenerative Diseases, country by countryIs Cholinesterase and Neurodegenerative Diseases research growing?
Output in 2022-2025 was 12% higher than in 2018-2021, peaking in 2023. The fastest-growing topics are Cholinesterase and Neurodegenerative Diseases.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Cholinesterase and Neurodegenerative Diseases as a percentage of every work published that year, 0.021% in 2024.
Fractional works of Cholinesterase and Neurodegenerative Diseases over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Cholinesterase and Neurodegenerative Diseases. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.